Patient Empowerment Via Mobile Health Applications (MHAs)

The goal of this observational study is to learn if myAria MHA can help adult oncology patients better manage their health and participate in medical research. The main questions it aims to answer are: * Does using the app improve patients' ability to track and self-manage symptoms? * Does the app increase engagement and willingness to share health data for research? * Does the app promote patient empowerment through the use of the nomograms? Participants will: * Install and use the patient-facing mobile app developed through the Agora3.0 project. * Regularly log symptom information, treatment side effects, and any changes in their daily well-being. * Complete brief, periodic questionnaires about their experience using the app. * Access the nomogram tool during consultation with doctor for discussion of results and treatment plan. * Consent (within the app) to share anonymized health data and survey responses with researchers. Through this project-funded by the Cypriot Research and Innovation Foundation and developed in partnership between GoC and Dcentric Health-Aria's ecosystem of products aims to empower oncology patients to take control of their care while contributing to ongoing medical research. Further, for the first time the use of nomogram and measurement of empowerment in prostate cancer will take place through the use of a co-developed (between researchers and patient representatives) questionnaire for testing its feasibility and validation.

Inclusion Criteria: * At least 18 and below 80 years of age * Prostate cancer diagnosis * Speak fluent English or Greek * Not had previous radiotherapy to the pelvis * Wishing to receive treatment at the German Oncology Center (GOC) or German Medical Institute (GMI) * Willing to take part in this research study, which lasts up to six months * Sign an informed consent form Exclusion Criteria: * Younger than 18 years or over 80 years of age * Other than prostate cancer diagnosis * Previous radiotherapy to the pelvis * Not wishing to receive treatment at the German Oncology Center (GOC) or German Medical Institute (GMI) * Not willing to take part in this research study * No signed informed consent form